Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke

• Status: Unknown status
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and efficacy of autologous peripheral hematopoietic stem cell transplantation in ischemic stroke.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zhejiang Hospital
• Collaborator: Zhejiang University
• Treatments: Antipyrine; Aspirin; Atorvastatin; Atorvastatin Calcium; Edaravone; Phenylmethylpyrazolone; Warfarin

Criteria

Inclusion Criteria:

• aged 40~70

• no consciousness disorders

• internal carotid artery territory infarction

• stroke happened < 1 year

• with stable hemiplegia, but remain dependent in daily life

• SSS(Scandinavian Stroke Scale) < 40

Exclusion Criteria:

• pregnant women

• can't tolerate the test because of other disease, such as heart failure, liver failure, renal failure, abnormal blood coagulation, AIDS, combine other tumor or special condition